Market Overview:
The global chronic migraine treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing prevalence of migraine, rising awareness about available treatments, and technological advancements in the field of migraine treatment. Based on type, the global chronic migraine treatment market is segmented into drug treatment and substitution treatment. Drug treatments are further classified into preventive drugs and abortive drugs. Substitution treatments are further classified into triptans and ergots. In terms of application, the global chronic migraine treatment market is segmented into hospitals, clinics, and others (home care settings). Some of the key players operating in this market include Alder Biopharmaceuticals Inc., Amgen Inc., Eli Lilly and Company,, Allergan plc,, Teva Pharmaceutical Industries Ltd.
Product Definition:
Chronic migraine treatment is the use of medications and therapies to prevent or reduce the frequency of chronic migraines. Chronic migraine treatment is important because it can help people to live more normal lives by reducing the number of headaches they experience.
Drug Treatment:
Drug treatment is the use of medications to reduce or eliminate chronic migraine pain. The drug treatments include prescription and over-the-counter (OTC) drugs. Prescription drugs are given by healthcare professionals, while OTC products can be bought from pharmacies without a prescription.
Substitution Treatment:
Substitution treatment is a method of altering the dosage or type of medication to relieve severe chronic pain. It's used in cases where other treatments such as Tramadol and Percocet are not effective enough.
Application Insights:
Based on application, the global chronic migraine treatment market is segmented into hospitals, clinics and other medical facilities, and others. The hospitals segment dominated the market in 2017 owing to factors such as a large patient base with complex migraine disorders requiring long-term care and medication management. Furthermore, rising prevalence of migraines among hospitalized patients is expected to drive demand for chronic migraine treatments over the forecast period.
The clinics & other medical facilities segment are anticipated to witness lucrative growth over the forecast period due to increasing awareness about effective treatment options for migraines along with growing adoption of these therapies by individuals preferring not to take medicine at home. For instance, Headache Management Clinic based in Toronto offers individualized therapy plans that include biofeedback training and cognitive behavioral therapy (CBT) for patients suffering from chronic headaches along with their families or caregivers free of charge under covered by health insurance policies or paid directly by insurers without any out-of-pocket expenses incurred.
Regional Analysis:
Europe dominated the global chronic migraine treatment market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing prevalence of this condition, rising awareness about available treatment options, and availability of reimbursement facilities for treatments. In addition, growing number of product launches in European countries is also anticipated to contribute towards growth over the forecast period.
Asia Pacific is expected to grow at a lucrative rate during the forecast period due to factors such as improving healthcare infrastructure and economic development that leads toward improvement in living standards & consumer awareness about chronic pain conditions like headache & migraine. Moreover, increase in disposable income levels will also boost demand for these products over next eight years from 2018 till 2030 time frame.
Growth Factors:
- Increasing prevalence of chronic migraine
- Growing awareness about chronic migraine and its treatment options
- Rising demand for effective and safe chronic migraine treatments
- Availability of new and innovative chronic migraine treatments
- Growing number of clinical studies on chronic migraine treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Chronic Migraine Treatment Market Research Report
By Type
Drug Treatment, Substitution Treatment
By Application
Hospitals, Clinics, Others
By Companies
Novartis, Pfizer, AstraZeneca, Allergan, GlaxoSmithKline, Eli Lilly, Merck, Johnson&Johnson, Zosano, Alder BioPharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global Chronic Migraine Treatment Market Report Segments:
The global Chronic Migraine Treatment market is segmented on the basis of:
Types
Drug Treatment, Substitution Treatment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Pfizer
- AstraZeneca
- Allergan
- GlaxoSmithKline
- Eli Lilly
- Merck
- Johnson&Johnson
- Zosano
- Alder BioPharmaceuticals
Highlights of The Chronic Migraine Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drug Treatment
- Substitution Treatment
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chronic Migraine Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chronic migraine treatment is a combination of medications and lifestyle changes that are aimed at reducing the frequency and severity of migraines. Treatment may include over-the-counter pain relievers, prescription medications, and lifestyle changes such as avoiding triggers.
Some of the major companies in the chronic migraine treatment market are Novartis, Pfizer, AstraZeneca, Allergan, GlaxoSmithKline, Eli Lilly, Merck, Johnson&Johnson, Zosano, Alder BioPharmaceuticals.
The chronic migraine treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chronic Migraine Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Chronic Migraine Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Chronic Migraine Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Chronic Migraine Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Chronic Migraine Treatment Market Size & Forecast, 2018-2028
4.5.1 Chronic Migraine Treatment Market Size and Y-o-Y Growth
4.5.2 Chronic Migraine Treatment Market Absolute $ Opportunity
Chapter 5 Global Chronic Migraine Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Chronic Migraine Treatment Market Size Forecast by Type
5.2.1 Drug Treatment
5.2.2 Substitution Treatment
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Chronic Migraine Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Chronic Migraine Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chronic Migraine Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chronic Migraine Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Chronic Migraine Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Chronic Migraine Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Chronic Migraine Treatment Market Size Forecast by Type
9.6.1 Drug Treatment
9.6.2 Substitution Treatment
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Chronic Migraine Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Chronic Migraine Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Chronic Migraine Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Chronic Migraine Treatment Market Size Forecast by Type
10.6.1 Drug Treatment
10.6.2 Substitution Treatment
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Chronic Migraine Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Chronic Migraine Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Chronic Migraine Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Chronic Migraine Treatment Market Size Forecast by Type
11.6.1 Drug Treatment
11.6.2 Substitution Treatment
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Chronic Migraine Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Chronic Migraine Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Chronic Migraine Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Chronic Migraine Treatment Market Size Forecast by Type
12.6.1 Drug Treatment
12.6.2 Substitution Treatment
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Chronic Migraine Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Chronic Migraine Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Chronic Migraine Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Chronic Migraine Treatment Market Size Forecast by Type
13.6.1 Drug Treatment
13.6.2 Substitution Treatment
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Chronic Migraine Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chronic Migraine Treatment Market: Competitive Dashboard
14.2 Global Chronic Migraine Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Pfizer
14.3.3 AstraZeneca
14.3.4 Allergan
14.3.5 GlaxoSmithKline
14.3.6 Eli Lilly
14.3.7 Merck
14.3.8 Johnson&Johnson
14.3.9 Zosano
14.3.10 Alder BioPharmaceuticals
